A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-income countries under a first of its...
Roche’s head of diagnostics, said the company aims to more than double production of tests from about 50 million a month to significantly more than 100 million a month by the end of the year
Britain is confident of developing antibody tests for immunity to the coronavirus and health officials are not discouraged by the ineffectiveness of early tests